Oramed Pharmaceuticals
ORMP
$2.30
Share price
-1.29%
Change (1 day)
-36.64%
Change (1 year)
Categories
Oramed Pharmaceuticals (ORMP) - Total assets
Total assets on the balance sheet as of December 2023 : $0.22 B
According to Oramed Pharmaceuticals's latest financial reports the company's total assets are $0.22 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Oramed Pharmaceuticals - Total assets on balance sheet (from 2005 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.22 B | 36.44% |
| 2022-12-31 | $0.16 B | |
| 2021-08-31 | $0.12 B | 186.78% |
| 2020-08-31 | $44.63 M | 28.76% |
| 2019-08-31 | $34.66 M | -26.87% |
| 2018-08-31 | $47.39 M | 22.43% |
| 2017-08-31 | $38.71 M | -9.61% |
| 2016-08-31 | $42.83 M | 62.52% |
| 2015-08-31 | $26.35 M | 20.88% |
| 2014-08-31 | $21.8 M | 151.76% |
| 2013-08-31 | $8.66 M | 63.56% |
| 2012-08-31 | $5.29 M | 22.4% |
| 2011-08-31 | $4.32 M | 198.16% |
| 2010-08-31 | $1.45 M | -55.52% |
| 2009-08-31 | $3.26 M | -40.77% |
| 2008-08-31 | $5.5 M | 184.31% |
| 2007-08-31 | $1.93 M | 999.38% |
| 2006-08-31 | $0.17 M | 13883.33% |
| 2005-08-31 | $0 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Novo Nordisk NVO | $43.25 B | 19,513.29% | 🇩🇰 Denmark |
 Sanofi SNY | $139.81 B | 63,293.95% | 🇫🇷 France |
 Ultragenyx RARE | $1.49 B | 576.04% | 🇺🇸 USA |
 Lexicon Pharmaceuticals
LXRX | $0.22 B | 4.03% | 🇺🇸 USA |
 Compugen CGEN | $0.12 B | -44.99% | 🇮🇱 Israel |